☰

Longest follow-up of melanoma patients treated with ipilimumab shows some survive up to ten years




Patients with advanced melanoma, who have been treated with the monoclonal antibody, ipilimumab, can survive for up to ten years, according to the largest analysis of overall survival for these patients.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/6...

Sábado, 28 de Septiembre 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección